The Effect of Uric Acid Lowering in Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

December 18, 2012

Primary Completion Date

September 22, 2015

Study Completion Date

September 22, 2015

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Febuxostat

Oral tablet, 80mg, OD, 8 weeks

Trial Locations (1)

M5G 2N2

Renal Physiology Laboratory, University Health Network, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Toronto General Hospital

OTHER

collaborator

University of Toronto

OTHER

lead

University Health Network, Toronto

OTHER

NCT02344602 - The Effect of Uric Acid Lowering in Type 1 Diabetes | Biotech Hunter | Biotech Hunter